Skip to main content

Together we are beating cancer

Donate now

Search Results: immunotherapy

Showing 12 out of 570 results
Non small cell lung cancer cells stained in pleural effusion sample.

A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE). A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE).

by Harry Jenkins | News | 12 January 2022

12 January 2022

Various medicines in packets.

In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed? In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed?

by Mads Thomsen | Analysis | 2 December 2021

2 December 2021

Lung cancer cells

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected. Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

by Harry Jenkins | News | 11 November 2021

11 November 2021

Elaine with husband Kilian

Elaine Whelan has pledged 10% of her estate to help fuel the research of tomorrow. Here, she tells us why she chose to support our work with a significant gift in her Will. Elaine Whelan has pledged 10% of her estate to help fuel the research of tomorrow. Here, she tells us why she chose to support our work with a significant gift in her Will.

by Michael Geraghty | Interview | 13 October 2021

13 October 2021

Amarvir (pictured with his dad Jag) was diagnosed with acute lymphoblastic leukaemia in 2010.

Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers. Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers.

by Harry Jenkins | Analysis | 29 September 2021

29 September 2021

How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset

by Cancer Research UK | Research Feature | 22 September 2021

22 September 2021

Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments. Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments.

by Cancer Research UK | Research Feature | 3 September 2021

3 September 2021